Detection of residual host cells in sex-mismatched bone marrow transplantation in various hematological diseases by fluorescence in situ hybridization

Japanese Journal of Cancer Research

Volumn 88, Issue 4, 1997, Pages 420-426

  Arif, Mansyur ^a   Tanaka, Kimio ^a   Kumaravel, Tirukalikundram Subrahmanyan ^a   Eguchi, Mariko ^a   Iwato, Kohji ^b   Dohy, Hiroo ^b   Kamada, Nanao ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

FISH; Residual host cells; Sex mismatched BMT

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; HEMATOLOGIC DISEASE; HOST CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; X CHROMOSOME; Y CHROMOSOME;

EID: 0030951918     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00399.x     Document Type: Article

References (35)

1. Socié, G., Landman, J., Gluckman, E., Devergie, A., Raynal, B., Esperou-Bourdeau, H. and Brison, O. Shortterm study of chimerism after bone marrow transplantation for severe aplastic anaemia. Br. J. Haematol., 80, 391-395 (1992).
2. Landman-Parker, J., Socié, G., Petit, T., Raynal, B., Bourhis, J. H., Pico, J. and Brison, O. Detection of recipient cells after non T-cell depleted bone marrow transplantation for leukemia by PCR amplification of minisatellites or of a Y chromosome marker has a different prognostic value. Leukemia, 8, 1989-1994 (1994).
3. Gehly, G. B., Bryant, E. M., Lee, A. M., Kidd, P. G. and Thomas, E. D. Chimeric BCR-ABL messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood, 78, 458-465 (1991).
4. Gerritsen, W. R., Jagiello, C. A. and Bourhis, J. H. Detection of chimerism in subpopulations of cells by fluorescence in situ hybridization and immunofluorescent staining of cell surface antigens. Bone Marrow Transplant., 13, 441-447 (1994).
5. Kogler, G., Wolf, H. H., Heyll, A., Arkesteijn, G. and Wernet, P. Detection of mixed chimerism and leukemic relapse after allogenic bone marrow transplantation in subpopulations of leukocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells. Bone Marrow Transplant., 15, 41-48 (1995).
6. Da Suva, M. A. P., Heerema, N. A., Lowe, L. R., Tricot, G. and Jansen, J. Cytogenetic patterns following bone marrow transplantation for chronic granulocytic leukemia. Cancer Genet, Cytogenet., 36, 35-44 (1988).
7. Stuppia, L., Calabrese, G., Franchi, P. G., Bartolomeo, P. D., Antonucci, A., Peila, R., Torlontano, G. and Palka, G. Detection of minimal residual disease by polymerase chain reaction in patients with different hematologic dis- eases treated by bone marrow transplantation. Cancer Genet. Cytogenet., 65, 88-92 (1993).
8. Hutchinson, R. M., Pringle, J. H., Potter, L., Patel, I. and Jeffreys, A. J. Rapid identification of donor and recipient cells after allogeneic bone marrow transplantation using specific genetic markers. Br. J. Haematol., 72, 133-140 (1989).
9. van den Berg, H., Vossen, J. M., van den Bergh, R. L., Bayer, J. and van Toi, M. J. D. Detection of Y chromosome by in situ hybridization in combination with membrane antigens by two-color immunofluorescence. Lab. Invest., 64, 623-628 (1991).
10. Nagler, A., Slavin, S., Yarkoni, S., Fejgin, M. and Amiel, A. Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization. Cancer Genet. Cytogenet., 73, 130-133 (1994).
11. Lawler, S. D., Baker, M. S., Harris, H. and Morgenstern, G. R. Cytogenetic studies on recipients of allogeneic bone marrow transplantation using the sex chromosomes as markers of cellular origin. Br. J. Haematol., 56, 431-443 (1984).
12. Zehnbaur, B., Griffin, C., Santos, G. and Wagner, J. Comparison of molecular and cytogenetic methods in the evaluation of engraftment following allogeneic bone marrow transplantation. Cancer Genet. Cytogenet., 55, 181-190 (1991).
13. Durnam, D. M., Anders, K. R., Fisher, L., O'quigley, J., Bryant, E. M. and Thomas, E. D. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood, 74, 2220-2226 (1989).
14. Wessman, M., Ruutu, T., Volin, L. and Knuutila, S. In situ hybridization using a Y-specific probe - a sensitive method for distinguishing residual male recipient cells from female donor cells in bone marrow transplantation. Bone Marrow Transplant., 4, 283-284 (1989).
15. Przepiorka, D., Gonzales-Chambers, R., Winkelstein, A., Rosenfeld, C. and Shadduck, R. K. Chimerism studies using in situ hybridization for the Y chromosome after T-cell depleted bone marrow transplantation. Bone Marrow Transplant., 5, 253-257 (1990).
16. Mitelman, F. "Guidelines for Cancer Cytogenetics," Supplement to An International System for Human Cytogenetic Nomenclature, (1991). Karger, Basel, Switzerland.
17. Wessman, M., Popp, S., Ruutu, T., Volin, L., Cremer, T. and Knuutila, S. Detection of residual host cells after bone marrow transplantation using non isotopic in situ hybridization and karyotype analysis. Bone Marrow Transplant., 11, 279-284 (1993).
18. Petit, T., Raynal, B., Socié, G., Landman-Parker, J., Bourhis, J. H., Gluckman, E., Pico, J. and Brison, O. Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell depleted bone marrow transplantation. Blood, 84, 3575-3583 (1994).
19. MacKinnon, S., Barnett, L., Heller, G. and O'Reilly, R. J. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood, 83, 3409-3416 (1994).
20. Petz, L. D., Yam, P., Wallace, R. B., Stock, A. D., de Lange, G., Knowlton, R. G., Brown, V. A., Donis-Keller, H., Hill, L. R., Forman, S. J. and Blume, K. G. Mixed hematopoietic chimerism following bone marrow transplantation for hematologiec malignancies. Blood, 70, 1331-1337 (1987).
21. Schattenberg, A., De Witte, T., Salden, M., Vet, J., van Dijk, B., Smeets, D., Hoogenhout, J. and Haanen, C. Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. Blood, 73, 1367-1371 (1989).
22. Frassoni, F., Sessarego, M., Bacigalupo, A., Strada, P., Repetto, M., Miceli, S., Occhini, D., DefTerrari, R. and Marmont, A. Competition between recipient and donor cells after bone marrow transplantation for chronic myeloid leukemia. Er. J. Haematol., 69, 471-475 (1988).
23. Cooperative Study Group on Chromosomes in Transplanted Patients. Cytogenetic follow-up of 100 patients submitted to bone marrow transplantation for Philadelphia chromosome-positive chronic myeloid leukemia. Eur. J. HaematoL, 40, 50-57 (1988).
24. Anastasi, J., Thangavelu, M., Vardiman, J. W., Hooberman, A. L., Bian, M. L., Larson, R. A. and Le Beau, M. M. Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of origin of relapse after allogeneic bone marrow transplantation. Blood, 77, 1087-1091 (1991).
25. Cross, N. C. P., Hughes, T. P., Feng, L., O'Shea, P., Bungey, J., Marks, D. I., Ferrant, A., Martiat, P. and Goldman, J. M. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: correlations with acute graftversus-host disease and relapse. Br. J. Haematol., 84, 67-74 (1993).
26. Hill, R. S., Peterson, F. B., Storb, R., Appelbaum, F. R., Doney, K., Dahlberg, S., Ramberg, R. and Thomas, E. D. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood, 67, 811-816 (1986).
27. Schmilz, N., Johannson, W., Schmidt, G., von der Helm, K. and Löffler, H. Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6. Blood, 70, 1099-1104 (1987).
28. Arthur, C. K., Apperley, J. F., Quo, A. P., Rassul, F., Gao, L. M. and Goldman, J. M. Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase. Blood, 71, 1179-1186 (1988).
29. Viard, F., Merel, P., Bilhou-Nabera, C., Marit, G., Comeau, F., Gharby, M. J., Febrer, F., Belloc, F., Lacombe, F., Broustet, A., Veson, G., Reifers, J. and Bernard, P. Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques. Bone Marrow Transplant., 11, 37-41 (1993).
30. Roth, M. S., Antin, J. H., Ash, R., Terry, V. H., Gotlieb, M., Silver, S. M. and Ginsburg, D. Prognostic significance of Philadelphia chromosome-positive cells detected by polymerase chain reaction after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Blood, 79, 276-282 (1992).
31. Gaiger, A., Lion, T., Kalhs, P., Mitterbauer, G., Henn, T., Haas, O., Födinger, M., Kier, P., Forstinger, C., Quehenberger, P., Hinterberger, W., Jäger, U., Linkesch, W., Mannhalter, C. and Lechner, K. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT). Leukemia, 7, 1766-1772 (1993).
32. Lee, M., Khouri, I., Champlin, R., Kantarjian, H., Talpaz, M., Trujillo, J., Freireich, E., Deisseroth, A. and Stass, S. Detection of minimal residual disease by polymerase chain reaction of BCR/ABL transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation. Br. J. Haematol., 82, 708-714 (1992).
33. Biernaux, C., Loos, M., Sels, A., Huez, G. and Stryckmans, P. Detection of major BCR-ABL gene expression at a very low level in blood cells of some healthy individuals. Blood, 86, 3118-3122 (1995).
34. Liu, Y., Hernandes, A. M., Shibata, D. and Cortopassi, G. A. BCL2 translocation frequency rises with age in humans. Proc. Natl. Acad. Sci. USA, 91, 8910-8914 (1994).
35. Butturini, A., Seeger, R. C. and Gale, R. P. Recipient immuno-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation. Blood, 68, 954-956 (1986).